Carbon Streaming Forms Independent Committee
May 13, 2024 07:00 ET
|
Carbon Streaming Corporation
Carbon Streaming Forms Independent Committee
GXO Receives 2023 Whirlpool Supply Chain Supplier Awards
May 13, 2024 07:00 ET
|
GXO Logistics
GREENWICH, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it has received two 2023 Supply...
Mirasol Identifies New Porphyry Targets at the El Potro Prospect and also Extends the VN-Zone by more than 3 km at the Sobek Copper-Gold Project in Vicuña District, Chile
May 13, 2024 07:00 ET
|
Mirasol Resources Ltd
Two new porphyry target areas, have been defined and supported by coincident alteration, geophysics and geochemistry The size of the alteration and mineralization footprint suggests that the VN-Zone...
Aya Gold & Silver Extends Main Zone to 5km and Adds 7 New Permits at Boumadine
May 13, 2024 07:00 ET
|
Aya Gold & Silver Inc.
Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) announces new high-grade drill results that extend the main mineralized trend by 800m to 5km.
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13, 2024 07:00 ET
|
Ovid Therapeutics Inc.
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to conquer epilepsies and meaningfully improve the lives...
Walden Biosciences Announces Research Collaboration with World Renowned Genetic Epidemiologist to Advance Work on Causal Role of suPAR in Chronic Kidney Disease
May 13, 2024 07:00 ET
|
Walden Biosciences, Inc.
CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company advancing disease-modifying therapies to transform the treatment...
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
May 13, 2024 07:00 ET
|
Galera Therapeutics
Galera's First Quarter 2024 Earnings Release
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
May 13, 2024 07:00 ET
|
Apogee Therapeutics, LLC
Initiated a Phase 2 clinical trial of APG777, a subcutaneous half-life extended monoclonal antibody targeting IL-13, in patients with moderate-to-severe atopic dermatitis, with 16-week...
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024
May 13, 2024 07:00 ET
|
Entera Bio Ltd.
JERUSALEM, May 13, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today...
Medicenna Provides Update on its Presentations at the 2024 ASCO Annual Meeting
May 13, 2024 07:00 ET
|
Medicenna Therapeutics Corp.
ASCO has informed the Company that the previously accepted MDNA11 oral abstract has been withdrawn due to alleged violation of their prior publication policy based solely on their review of the...
- May 13, 2024 07:00 ET Medicenna Provides Update on its Presentations at the 2024 ASCO Annual Meeting
- May 13, 2024 07:00 ET Aya Gold & Silver Extends Main Zone to 5km and Adds 7 New Permits at Boumadine